Interruptions of Antiretroviral Therapy in HIV Infection : Are they Detrimental to Neurocognitive Functioning ?

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The Trail Making Test

  2017cited by this paper
• The California verbal learning test

  2016cited by this paper
• HIV-associated cognitive impairment before and after the advent of combination therapy

  2011cited by this paper
• Cognitive functioning during highly active antiretroviral therapy interruption in human immunodeficiency virus type 1 infection

  2011cited by this paper
• Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: A combined study of two cohorts

  2011cited by this paper
• Prevalence and Prognostic Significance of ECG Abnormalities in HIV-infected Patients: Results from the Strategies for Management of Antiretroviral Therapy (SMART) Study

  2011influential reference
• Antiretroviral drug treatment interruption in human immunodeficiency virus-infected adults: Clinical and pathogenetic implications for the central nervous system

  2011cited by this paper
• Inflammatory changes and breakdown of microvascular integrity in early human immunodeficiency virus dementia

  2011cited by this paper
• Is it smart to continue to study treatment interruptions?

  2009cited by this paper
• Changes in Cognition During Antiretroviral Therapy: Comparison of 2 Different Ranking Systems to Measure Antiretroviral Drug Efficacy on HIV-Associated Neurocognitive Disorders

  2009cited by this paper
• CD4 cell-guided scheduled treatment interruptions in HIV-infected patients with sustained immunologic response to HAART.

  2009cited by this paper
• Early antiretroviral treatment prevents the development of central nervous system abnormalities in simian immunodeficiency virus-infected rhesus monkeys

  2009cited by this paper
• Prognostic factors of long‐term CD4+count‐guided interruption of antiretroviral treatment

  2009cited by this paper
• CD4+ guided antiretroviral treatment interruption in HIV infection: a meta-analysis.

  2008cited by this paper
• Nadir CD4 Cell Count Predicts Neurocognitive Impairment in HIV-Infected Patients

  2008influential reference
• HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy

  2008cited by this paper
• Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system.

  2008cited by this paper
• Symbol Digit Modalities Test(SDMT)의 유용성

  2007influential reference
• Updated research nosology for HIV-associated neurocognitive disorders

  2007cited by this paper
• Antiretroviral therapy interruption guided by CD4 cell counts and plasma HIV-1 RNA levels in chronically HIV-1-infected patients

  2007cited by this paper
• Variable benefit in neuropsychological function in HIV-infected HAART-treated patients

  2006influential reference
• An immune control model for viral replication in the CNS during presymptomatic HIV infection.

  2006cited by this paper
• Altered hippocampal-prefrontal activation in HIV patients during episodic memory encoding

  2006cited by this paper
• Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996 to 2002: Results from an urban observational cohort

  2005cited by this paper
• Neuropsychological aspects of coinfection with HIV and hepatitis C virus.

  2005cited by this paper
• Neurocognitive Impairment and Survival in a Cohort of HIV-Infected Patients Treated with HAART

  2005influential reference
• Viral Rebound Syndrome in Two HIV-1–Positive Patients after Structured Treatment Interruption

  2005cited by this paper
• HIV-1 chemokine coreceptor utilization in paired cerebrospinal fluid and plasma samples: a survey of subjects with viremia.

  2005cited by this paper
• Influence of Prior Structured Treatment Interruptions on the Length of Time without Antiretroviral Treatment in Chronically HIV-Infected Subjects

  2004cited by this paper
• Prevalence of cognitive disorders differs as a function of age in HIV virus infection

  2004cited by this paper
• Effect of prolonged discontinuation of successful antiretroviral therapy on CD4 T cells: a controlled, prospective trial

  2004cited by this paper
• Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders

  2004cited by this paper
• Human immunodeficiency virus-1 RNA levels in cerebrospinal fluid exhibit a set point in clinically stable patients not receiving antiretroviral therapy.

  2003cited by this paper
• Scoring Reliability on the Wechsler Adult Intelligence Scale-Third Edition (WAIS-III)

  2003influential reference
• Progression to neuropsychological impairment in human immunodeficiency virus infection predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA.

  2002cited by this paper
• Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection

  2002cited by this paper
• Warning: antiretroviral treatment interruption could lead to an increased risk of HIV transmission.

  2002cited by this paper
• Effect of prolonged discontinuation of successful antiretroviral therapy on CD4+ T cell decline in human immunodeficiency virus-infected patients: implications for intermittent therapeutic strategies.

  2002cited by this paper
• Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia.

  2001cited by this paper
• The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection

  2001cited by this paper
• Cerebrovascular changes in the basal ganglia with HIV dementia

  2000cited by this paper
• HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression.

  1999cited by this paper
• Rate of HIV-1 RNA rebound upon stopping antiretroviral therapy.

  1999cited by this paper
• Independent Evolution of HIV Type 1 in Different Brain Regions

  1999cited by this paper
• Norms for Letter and Category Fluency: Demographic Corrections for Age, Education, and Ethnicity

  1999cited by this paper
• Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome

  1997cited by this paper
• Statistical Power Analysis for the Behavioral Sciences (2nd ed.)

  1989cited by this paper
• Cognitive therapy in depression.

  1980cited by this paper
• Stroop Color and Word Test: Manual for Clinical and Experimental Uses.

  1978cited by this paper
• Clinical neuropsychology: Current status and applications.

  1975influential reference
• Manual for the State-Trait Anxiety Inventory

  1970cited by this paper

• Neuropsychological Characteristics of Adults with HIV: A Systematic Review

  2021cites this paper
• HIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment

  2017cites this paper
• Viral and inflammatory markers in cerebrospinal fluid of patients with HIV‐1‐associated neurocognitive impairment during antiretroviral treatment switch

  2015cites this paper
• Penetration and antiviral activity of antiretroviral drugs in the Central Nervous System

  2015cites this paper
• Classification Models for Neurocognitive Impairment in HIV Infection Based on Demographic and Clinical Variables

  2014cites this paper
• HIV-1-assoziierte neurokognitive Störung

  2014cites this paper
• A Brief and Feasible Paper-Based Method to Screen for Neurocognitive Impairment in HIV-Infected Patients: The NEU Screen

  2013cites this paper